ChromaDex Corp. (CDXC)

[MinnieM]

There have been some trials done in humans. Following is the list:

https://clinicaltrials.gov/ct2/results?term=nicotinamide+riboside&Search=Search&flds=abcefgps

The 140 patient trial is projected for primary completion in June 2017, but, those dates are estimates. And, once done, it takes time to get data out.

Safety has been established in several, albeit in small trials.

Increase in NAD+ has been established in the 120 person study.

I started taking Niagen and pterostilbene in May 2017 shortly after a physical and I've had several physicals since then. Some of my early posts describe the success I've had with it.

Regarding the stock, I have no thoughts on what it does. I primarily follow the company for a couple of ingredients I use.

Milarepa... thanks for posting the legal updates.

Hope that helps.






In Reply to 'BlackBat'
Niagen, the main Chromadex product, does appear to have fantastic potential.

However, the lack of clinical trial data on humans, as opposed to mice, is probably stopping a lot of people jumping in and:

a) Buying shares in it
b) Actually using it - though at the price it is probably cheaper than a daily Mars Bar.

Reading the CEOs letter dated Feb. 23, 2017, he states that a clinical trial involving 140 people is underway, but gives no timescale as to when it will be concluded.

If the results from this trail are positive, and the current court case is successfully resolved, then I would think most people who are currently undecided would jump in, and the stock begin to move.

So, is there any indication as to when the latest clinical trail will be concluded?

Cheers,

BlackBat